|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
250 a.a.
|
 |
|
|
|
|
|
|
|
244 a.a.
|
 |
|
|
|
|
|
|
|
241 a.a.
|
 |
|
|
|
|
|
|
|
242 a.a.
|
 |
|
|
|
|
|
|
|
233 a.a.
|
 |
|
|
|
|
|
|
|
244 a.a.
|
 |
|
|
|
|
|
|
|
243 a.a.
|
 |
|
|
|
|
|
|
|
222 a.a.
|
 |
|
|
|
|
|
|
|
204 a.a.
|
 |
|
|
|
|
|
|
|
198 a.a.
|
 |
|
|
|
|
|
|
|
212 a.a.
|
 |
|
|
|
|
|
|
|
222 a.a.
|
 |
|
|
|
|
|
|
|
233 a.a.
|
 |
|
|
|
|
|
|
|
196 a.a.
|
 |
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
Proteasome inhibition by fellutamide b
|
|
Structure:
|
 |
Pre8 isoform 1. Chain: a, o. Pre9 isoform 1. Chain: b, p. Pre6 isoform 1. Chain: c, q. Pup2 isoform 1. Chain: d, r. Pre5 isoform 1.
|
|
Source:
|
 |
Saccharomyces cerevisiae. Brewer's yeast. Organism_taxid: 4932. Strain: bakers yeast. Other_details: native purification from cell lysate. Synthetic: yes. Synthetic construct. Organism_taxid: 32630
|
|
Resolution:
|
 |
|
2.60Å
|
R-factor:
|
0.240
|
R-free:
|
0.266
|
|
|
Authors:
|
 |
M.Groll,J.Hines,M.Fahnestock,M.C.Crews
|
|
Key ref:
|
 |
J.Hines
et al.
(2008).
Proteasome inhibition by fellutamide B induces nerve growth factor synthesis.
Chem Biol,
15,
501-512.
PubMed id:
|
 |
|
Date:
|
 |
|
07-May-08
|
Release date:
|
10-Jun-08
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P23639
(PSA2_YEAST) -
Proteasome subunit alpha type-2 from Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
250 a.a.
250 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P23638
(PSA3_YEAST) -
Proteasome subunit alpha type-3 from Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
258 a.a.
244 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P40303
(PSA4_YEAST) -
Proteasome subunit alpha type-4 from Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
254 a.a.
241 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P32379
(PSA5_YEAST) -
Proteasome subunit alpha type-5 from Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
260 a.a.
242 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P40302
(PSA6_YEAST) -
Proteasome subunit alpha type-6 from Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
234 a.a.
233 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P21242
(PSA7_YEAST) -
Probable proteasome subunit alpha type-7 from Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
288 a.a.
244 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P21243
(PSA1_YEAST) -
Proteasome subunit alpha type-1 from Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
252 a.a.
243 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P25043
(PSB2_YEAST) -
Proteasome subunit beta type-2 from Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
261 a.a.
222 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P25451
(PSB3_YEAST) -
Proteasome subunit beta type-3 from Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
205 a.a.
204 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P22141
(PSB4_YEAST) -
Proteasome subunit beta type-4 from Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
198 a.a.
198 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P30656
(PSB5_YEAST) -
Proteasome subunit beta type-5 from Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
287 a.a.
212 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P23724
(PSB6_YEAST) -
Proteasome subunit beta type-6 from Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
241 a.a.
222 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains H, K, N, V, Y, 2:
E.C.3.4.25.1
- proteasome endopeptidase complex.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Cleavage at peptide bonds with very broad specificity.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Chem Biol
15:501-512
(2008)
|
|
PubMed id:
|
|
|
|
|
| |
|
Proteasome inhibition by fellutamide B induces nerve growth factor synthesis.
|
|
J.Hines,
M.Groll,
M.Fahnestock,
C.M.Crews.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Neurotrophic small molecules have the potential to aid in the treatment of
neuronal injury and neurodegenerative diseases. The natural product fellutamide
B, originally isolated from Penicillium fellutanum, potently induces nerve
growth factor (NGF) release from fibroblasts and glial-derived cells, although
the mechanism for this neurotrophic activity has not been elucidated. Here, we
report that fellutamide B potently inhibits proteasome catalytic activity.
High-resolution structural information obtained from cocrystallization of the
20S proteasome reveals novel aspects regarding beta-subunit binding and adduct
formation by fellutamide B to inhibit their hydrolytic activity. We demonstrate
that fellutamide B and other proteasome inhibitors increased NGF gene
transcription via a cis-acting element (or elements) in the promoter. These
results demonstrate an unrecognized connection between proteasome inhibition and
NGF production, suggesting a possible new strategy in the development of
neurotrophic agents.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
J.Clerc,
N.Li,
D.Krahn,
M.Groll,
A.S.Bachmann,
B.I.Florea,
H.S.Overkleeft,
and
M.Kaiser
(2011).
The natural product hybrid of Syringolin A and Glidobactin A synergizes proteasome inhibition potency with subsite selectivity.
|
| |
Chem Commun (Camb),
47,
385-387.
|
 |
|
|
|
|
 |
P.M.Joyner,
and
R.H.Cichewicz
(2011).
Bringing natural products into the fold - exploring the therapeutic lead potential of secondary metabolites for the treatment of protein-misfolding-related neurodegenerative diseases.
|
| |
Nat Prod Rep,
28,
26-47.
|
 |
|
|
|
|
 |
T.Roemer,
D.Xu,
S.B.Singh,
C.A.Parish,
G.Harris,
H.Wang,
J.E.Davies,
and
G.F.Bills
(2011).
Confronting the challenges of natural product-based antifungal discovery.
|
| |
Chem Biol,
18,
148-164.
|
 |
|
|
|
|
 |
A.Baldisserotto,
C.Franceschini,
F.Scalambra,
C.Trapella,
M.Marastoni,
F.Sforza,
R.Gavioli,
and
R.Tomatis
(2010).
Synthesis and proteasome inhibition of N-allyl vinyl ester-based peptides.
|
| |
J Pept Sci,
16,
659-663.
|
 |
|
|
|
|
 |
J.J.La Clair
(2010).
Natural product mode of action (MOA) studies: a link between natural and synthetic worlds.
|
| |
Nat Prod Rep,
27,
969-995.
|
 |
|
|
|
|
 |
P.P.Geurink,
B.I.Florea,
G.A.Van der Marel,
B.M.Kessler,
and
H.S.Overkleeft
(2010).
Probing the proteasome cavity in three steps: bio-orthogonal photo-reactive suicide substrates.
|
| |
Chem Commun (Camb),
46,
9052-9054.
|
 |
|
|
|
|
 |
J.Clerc,
B.I.Florea,
M.Kraus,
M.Groll,
R.Huber,
A.S.Bachmann,
R.Dudler,
C.Driessen,
H.S.Overkleeft,
and
M.Kaiser
(2009).
Syringolin A selectively labels the 20 S proteasome in murine EL4 and wild-type and bortezomib-adapted leukaemic cell lines.
|
| |
Chembiochem,
10,
2638-2643.
|
 |
|
|
|
|
 |
J.Clerc,
M.Groll,
D.J.Illich,
A.S.Bachmann,
R.Huber,
B.Schellenberg,
R.Dudler,
and
M.Kaiser
(2009).
Synthetic and structural studies on syringolin A and B reveal critical determinants of selectivity and potency of proteasome inhibition.
|
| |
Proc Natl Acad Sci U S A,
106,
6507-6512.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.Lakomek,
A.Dickmanns,
M.Kettwig,
H.Urlaub,
R.Ficner,
and
T.Lübke
(2009).
Initial insight into the function of the lysosomal 66.3 kDa protein from mouse by means of X-ray crystallography.
|
| |
BMC Struct Biol,
9,
56.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Groll,
R.Huber,
and
L.Moroder
(2009).
The persisting challenge of selective and specific proteasome inhibition.
|
| |
J Pept Sci,
15,
58-66.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
| |